Hjem › Multipelt myelom › New Jersey › Clifton
Kliniske studier for Multipelt myelom i Clifton, NJ
14 studier for Multipelt myelom søker deltakere på steder i og rundt Clifton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekruttererFase 4
- Hackensack University Medical Center, Hackensack · 7 mi unna
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
RekruttererFase 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi unna
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
RekruttererFase 2
- John Theurer Cancer Center, Hackensack · 7 mi unna
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- Hackensack Meridian Health, Hackensack · 7 mi unna
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi unna
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- Research Site, Hackensack · 7 mi unna
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
Mosaic Trial for Stem Cell Transplant Recipients
Rekrutterer
- Hackensack Meridian Health, Nutley · 3 mi unna
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Hackensack · 7 mi unna
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
RekruttererFase 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi unna
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Clifton
- Ikke-småcellet lungekreft24 studier
- Kreft (alle typer)15 studier
- Metastatisk kreft12 studier
- Akut myelogen leukemi12 studier
- Prostatakreft12 studier
- Brystkreft12 studier
- Eggstokkreft11 studier
- Lungekreft10 studier
- Endometriekreft8 studier
- Tripelnegativ brystkreft8 studier
- Kolorektal kreft8 studier
- Plateepitelcancer i hode og hals8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.